Ibuprofen (APO-Ibuprofen 400)
Ibuprofen risk profile, scheduling, and guidance for claims professionals and care workers . Also known as APO-Ibuprofen 400, WGR-IBUPROFEN 400, Brufen.
Ibuprofen (brand names: APO-Ibuprofen 400, WGR-IBUPROFEN 400, Brufen) is classified as Low risk (1 risk points) by AllMeds. It is a S2 medication under the TGA in Australia. NSAID with low workplace safety risk unless used with anticoagulants or in high doses.
Key Takeaways
- TGA Schedule: S2 in Australia
- Risk level: Low (1 points)
- Recommended maximum duration: 30 days
- PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | S2 | PBS listed |
Risk Profile
NSAID with low workplace safety risk unless used with anticoagulants or in high doses.
Regulatory and Compliance Guidance
When Ibuprofen appears on a claimant's medication list, claims professionals should assess whether the prescribing is appropriate for the compensable injury, whether the duration is within guidelines, and whether there are interactions with other medications on the claim.
Australia TGA / PBS / State Schemes
Classified as S2 under the Therapeutic Goods Administration (TGA).
Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.
United Kingdom NICE / MHRA / FPM
NICE NG59 (Low Back Pain and Sciatica) recommends considering oral NSAIDs for short-term pain management, taking into account risk factors including GI, cardiovascular, and renal risks.
Need to assess this medication across your caseload?
Run a full risk assessment including Ibuprofen interactions and compliance checks.
AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.
No credit card required. No signup for your first 2 questions.
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.